for diarrhea prevention and cure. 2 Despite the well-known fact that diarrheal diseases are transmitted by fecal oral route 3 inexorable outbreaks continue to be a scourge globally. 4 Infectious milieu of diarrhea shed light on its multifactorial nature and vast array of disease etiology. 5 Virulence arsenal of etiological agents varies with geographical features and become significantly evident in choice of treatment protocol. Therefore, for a successful treatment regime, identification of etiological agents is of utmost significance.
Escherichia coli is enormously versatile bacterium which elaborates its commensal and pathogenic potential in human host. Diarrheagenic E. coli (DEC) is reported as one of the leading causes of gastrointestinal disorders worldwide and signified as an important issue to address in public health. [6] [7] [8] [9] In low-to middle-income countries, >40%
of diarrheal episodes among children are caused by diarrheagenic E. coli pathotypes. 10 These pathotypes also play a considerable role in diarrhea morbidity in the Indian population. [11] [12] [13] Remarkably, distinct DEC pathotypes display specific virulence arsenal which transforms the predominant repertoire available for diagnostic and therapeutic approaches. DEC is further catalogued into various pathotypes based upon occurrence of these unique virulence determinants contributing to specific pathophysiology, 14 viz. Enteropathogenic E. coli (eae, bfpA), enterotoxigenic E. coli (eltB, and estA), enteroaggregative E. coli (pCVD), enterohemorrhagic E. coli (vt1 and vt2), and enteroinvasive E. coli (ial). [14] [15] [16] Enteropathogenic E. coli (EPEC) is frequently associated with diarrhea incidences from both community and healthcare settings. EPEC has been categorized into atypical and typical EPEC by the presence of eae gene alone and simultaneous expression of bfpA and eae genes, respectively. 14, 15 Enterotoxigenic E. coli (ETEC), another E. coli, has been reported as a significant pathogenic form responsible for diarrhea in travelers and population inhabiting endemic regions globally. 12, 17, 18 ETEC in the stool specimen may be confirmed by amplification of two marker genes estA and eltB, which encode heat stable and heat labile secretory enterotoxins, respectively.
Since the last decade, several reports have been published for identification of adherent enteroaggregative E. coli (EAEC) as an emerging enteropathogen responsible for adult and childhood diarrhea worldwide. [19] [20] [21] [22] The plasmid-encoded gene probe pCVD which elucidate aggregative phenotype is utilized for identification of EAEC in diagnostic and epidemiological studies. 12, 18, 23 Another molecular pathotypes of E. coli, enterohemorrhagic E. coli (EHEC), a subgroup of Shiga toxin-producing E. coli and enteroinvasive
E. coli (EIEC) cause a devastating form of gastrointestinal infections
which may lead to severe life-threatening complications like hemolytic uremic syndrome (HUS). EHEC colonizes large intestine and secretes toxins. 14 EIEC invades small bowel enterocytes and is regarded a true intracellular pathogen. However, both EIEC and EHEC display low levels of incidences.
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Escherichia coli serogrouping is used as a conventional method for pathogen characterization and diagnosis. 14, 15 Besides, potential use of O antigen characterization, DEC associations with O antigens varies across different geographical regions. 25, 26 As DEC pathotypes possess a large number of different "O" somatic antigen; therefore, their continuous monitoring is helpful in subtyping strains and enhancing phylogenetic studies.
As diarrheal disease is generally self-limiting, antidiarrheal agents are not usually recommended for treatment of diarrhea. 27 However, traveler's diarrhea, persistent diarrhea, and acute invasive diarrhea display high severity of infection and extended recovery periods which reinforce the use of antimicrobials such as ampicillin, norfloxacin, nalidixic acid, cefixime, and cotrimoxazole. [27] [28] [29] [30] Several investigations have been conducted to study the prevalence of DEC pathotypes in different parts of India. 12 and clinical symptoms was also analyzed. The study also encompasses resistance patterns of identified E. coli pathotypes, which will be useful in treatment regimes for tackling these specific pathogens.
| MATERIALS AND METHODS

| Culture media and reagents
MacConkey agar, eosin methylene blue agar, Muller Hinton agar, nutrient agar, LB broth, and agar for conventional culture techniques were purchased from Hi-media Laboratories Pvt. Ltd., Mumbai, India.
Agarose, saturated phenol, sodium acetate, antibiotic disks (ampicillin 10 μg, cefixime 5 μg, cotrimoxazole 75 μg, norfloxacin 10 μg, and nalidixic acid 30 μg), and E-strips were also purchased from Hi-media Laboratories Pvt. Ltd., Mumbai, India. PCR master mix and 100-bp DNA ladder were purchased from Promega, Thermo Fisher Scientific, and New England Biolabs (NEB). Chloroform, isoamyl alcohol, and ethanol of analytical grades were purchased from Merck. Primers utilized in this study were purchased from Integrated DNA Technologies, Bangalore, India.
| Study sites and clinical specimens
From February 2013 to April 2016, a total of 572 stool specimens of diarrheal patients aged between 13 days and 85 years were collected.
Samples were collected from patients with primary complaint of three or more loose stools/day who were admitted to Regional hospital, 
| Isolation and detection of DEC
| DNA extraction and 16S rRNA gene characterization
Biochemically confirmed strains were initially molecularly characterized using 16S rRNA gene for E. coli. 33 
| Molecular characterization of DEC pathotypes
DEC molecular pathotypes were identified by amplification of virulent genes. Primer sequences were selected from two published studies and are given in Table S1 . 17, 18 Initially, molecular pathotypes were amplified in a multiplex PCR followed by single gene PCR for identification and reproducibility of specific DEC pathotypes. Different molecular pathotypes were identified on the basis of amplification of following amplicons of genes; ETEC encoded heat stable (estA 147bp 17, 18 ) and heat labile toxin (eltB of 322bp 17 or 508 bp 18 ) genes, EPEC encoded bundle pilus-forming gene (bfpA 367bp 17, 18 ) and in- were stringently amplified by single gene PCR. PCR thermocycling conditions for pathotypes were same as described above for amplification of 16S rRNA gene. Amplified PCR products were further confirmed by commercial Sanger sequencing at various time intervals during study. Sequenced DEC pathotypes were taken as positive control in PCR.
| Serological characterization
Identification of bacterial somatic O antigen was performed by standard agglutination test using 176 "O"-specific antisera. 34 For serogroups characterization, biochemically and molecularly confirmed E. coli isolates were screened at National Salmonella and E. coli center hours was regarded as "untypeable."
| Antimicrobial susceptibility test (AST) and minimum inhibitory concentration determination (MIC)
The antimicrobial susceptibility of the PCR-positive E. coli pathotypes was determined by standard Kirby Bauer's disk diffusion method were determined using the E test. Escherichia coli ATCC 25922 was used as reference strains for quality control in AST and MIC tests.
Results were interpreted according to CLSI and ICMR guidelines. 
| Statistical analysis
The age of the patients was classified into five groups, viz., <2 years, 3-5 years, 6-17 years, 18-65 years, and >65 years. In statistical analysis >65 years age represented the most normative group because elderly from developing countries are more prone to diarrheal infection due to immunocompromised status. 37 In a similar study by Dutta et al, 12 2012, elderly age group comprising subjects >65 years of age were also taken as reference for comparative statistical analysis. 
| RESULTS
| Identification and molecular characterization of E. coli
During February 2013 to April 2016, a total of 572 stool specimens were collected from diarrheal patients admitted to regional (Govt. hospital Solan) and tertiary care hospital (Indira Gandhi Medical College, Shimla) in Himachal Pradesh, a hilly state of India. Hospitalized patients presented a very wide age group window ranging from 13 days to 85 years. A total of two hundred forty-seven (n = 247) patients < 5 years of age and three hundred twenty-five patients (n = 325) aged >5 years were analyzed in this study. Standard microbiological techniques and biochemical assays showed the presence of diarrheagenic E. coli in stool specimens of diarrhea patients.
| Incidences of DEC molecular pathotypes in study population
Identification of diarrheagenic E. coli pathotypes was performed on the basis of biochemical, molecular, and serological assays. All biochemically characterized E. coli were also confirmed by 16S rRNA gene amplification ( Figure S1A ). Further, DEC molecular pathotypes were identified by amplification of virulence gene-specific primers selected according to pathotype classification system devised by Nataro and Kaper 14 ( Figures S1B-D) . Overall, diarrheagenic E. coli accounted for a proportion of approximately 21% (n = 120/572) in hospitalized patients. Among distinct DEC pathotypes, EPEC (n = 79/572, 13.8%) was found to be predominant pathotype followed by ETEC (n = 33/572, 5.8%) and EAEC (n = 8/572, 1.4%). Pathotypes belonging to classes EHEC and EIEC of DEC were not found in analyzed specimens. The amplified products of PCR were further confirmed by sequencing, and partial coding sequences obtained were found to be 100% similar to targeted reference genes. The gene sequences were submitted to NCBI database (NCBI accessions: KX911251, KX911252, KX911253, and KX911255) and were utilized as positive control in subsequent PCR analysis (Data S1-S6).
| Distribution of virulent genomic elements among DEC molecular pathotypes
Characterization of DEC molecular pathotype was ascertained on amplification of either distinct gene or combination of genes (Table S1 ).
In this study, eae gene of atypical EPEC (62.5% eae gene, n = 75/120) was most prevalent as compared to typical EPEC (3.3% eae & bfpA, n = 4/120). In case of ETEC-infected patients, strains harboring estA (18.3%, n = 22/120) were more prevalent than strains possessing both estA and eltB genes (10%, n = 12). All EAEC strains (n = 8) possessed pCVD (6.6%, 8 of 120) gene.
| Clinical symptoms Vs DEC molecular pathotypes
Clinical symptoms of DEC pathotype-mediated infection vary from acute to persistent diarrhea, febrile, or afebrile, with or without symptoms of dehydration. Besides, loose stools as a common illness among study population, symptoms of fever, vomit, dehydration, mucus, and abdominal pain were also observed. To ascertain DEC molecular pathotype-specific clinical symptoms, chi-square analysis was performed, and P values and odds ratio (OR) at 95% confidence interval (CI) were calculated (Table 1) . For comparison, DEC-positive population (n = 120) was taken as positive control, and population without DEC infection (n = 452) was utilized as negative control. Symptoms of watery stools, visible mucus were found statistically associated with DEC pathotype infection. Other pathophysiological features such as vomiting, severe dehydration, and fever were also observed with higher frequency in EPEC and ETEC pathotypes, but similar cases were also observed in DEC-negative population therefore statistically insignificant. While, EAEC infection was found primarily associated with the frequent bowl movements (>6 episodes of watery stool), fever, vomiting, and dehydration.
| Age group distribution of DEC molecular pathotypes
For determination of high-risk age groups, study population was stratified into five various age groups, viz. children 0-2 years (n = 202) and To recognize specificity of any DEC pathotype to particular age groups, bivariate Fisher analysis was performed ( Table 2 ). Statistically significant correlations were observed for EPEC, ETEC, and EAEC pathotypes with those of children <2 years of age. However in adult age group (17-65 years), only EPEC and ETEC prevalence were correlated significantly. 
| Serogroup analysis of DEC pathotypes
| Antimicrobial resistance in DEC molecular pathotypes
Several studies have been performed for analyzing antibiotic resistance patterns among diarrheagenic E. coli isolates. [27] [28] [29] [30] Therefore, molecular pathotypes of DEC were also screened for antibiogram patterns by antimicrobial susceptibility test (AST) and minimum inhibitory concentration (MIC) according to CLSI guidelines. 36 Antibiotics utilized in screening were chosen on the basis of ICMR recommendations 30 ( Figure S2A & Figure S2B ). AST and MIC revealed that a majority of diarrheagenic E. coli strains were sensitive for cotrimoxazole (36%), while <20% were sensitive for cefixime, norfloxacin, ampicillin, and nalidixic acid ( On correlating resistance pattern with distinct DEC pathotype, EPEC strains were observed to be most resistant against all tested drugs. ETEC strains were found 18-49% sensitive against all tested antibiotics. EAEC pathotypes showed highest sensitivity for cotrimoxazole (62.5%), norfloxacin (37.5%), nalidixic acid, and cefixime (25% in both). Table 3 showed statistical analysis using chi-square test performed to evaluate pathotype-specific antibiotic resistance level. All molecular DEC pathotypes were found to possess significant levels of antibiotic resistance against all antibiotics.
| DISCUSSION
Successful interventions in management of infectious diseases need identification of the etiological agent and treatment of clinical symptoms manifested during disease. Diarrhea is a multifactorial illness associated with wide spectrum of pathogens including viruses, bacteria, and parasites. 38, 39 Conventional microbiological techniques combined with molecular identification system incredibly increases reproducibility and scalability of etiological agent characterization. 40 However, Himachal Pradesh, a Northern hilly state of India. 45 The current study was aimed at elucidating the frequency of DEC pathotypes using virulence gene markers in moderate-to-severe diarrhea population of Himachal Pradesh. Prior to this study, there have been no reports from present region addressing DEC incidences. Therefore, it is of utmost importance to address DEC-associated diarrheal incidences to provide a comprehensive view of diarrhea etiology within the region which will facilitate further epidemiological and therapeutic prospects.
The diarrhea study cases involved in comprehensive investigation belonged to a broad window of age, from 13 days to 85 years.
Therefore, the study population was stratified into five different age groups (0-2 years, 3-5 years, 6-17 years, 18-65 years, and >65 years), and age group >65 years was taken as reference group for statistical analysis. The incidence rates of diarrheagenic E. coli were observed up to 21% as the sole pathogen and approximately 6% as mixed infection AMP, ampicillin; COT, cotrimoxazole; CPM, cefixime; NOR, norfloxacin, and NAL, nalidixic acid. Statistically significant values (*P < .05, **P < .01 (chi-square test), for the comparison of the resistance percentage among the different E. coli).
T A B L E 3 Antibiotic resistance among the different diarrheagenic Escherichia coli groups in patients with diarrhea
with Rotavirus. Our study shows moderate DEC infection rates, similar to the reports from developing world. [46] [47] [48] [49] However, reports from other parts of India and neighboring countries showed 10-35% variation in DEC incidence rates. [11] [12] [13] 50, 51 Sporadic outbreaks with 42% to 65% of incidences are also reported from different regions of India. EAEC pathotype is known to cause disease via multiple mechanisms; adherence to mucosa, secretion of toxins, and mucosal inflammation. 22 The EAEC enteropathogen was identified by using pCVD gene probe. We observed EAEC predominantly in children (n = 7/8) The global spread of antimicrobial resistant strains threatens the effective prevention and treatment of enteric infections caused by Gram-negative bacteria. E. coli has become increasingly resistant to conventional and commonly used antibiotics in hospital and community settings, 26, 77 and certainly poses serious threat to the management of infectious diseases.
We examined the DEC pathotypes resistance against five antibiotics: ampicillin, cefixime, norfloxacin, nalidixic acid, and cotrimoxazole belonging to class quinolones and β-lactams. These antibiotics are in accordance with Centre for Disease Control and Prevention and also advised by ICMR. 27, 30 In the present study, EPEC was found as most the resistant pathotype, and highest levels of antibiotic resistance were observed against ampicillin. These observations are concordance with previous studies analyzing DEC resistance. 78, 79 We observed lowest resistance rates against cotrimoxazole among all DEC pathotypes. However, Sadeghabadi and coworkers reported approximately 80% resistance against cotrimoxazole in diarrheagenic E. coli. Similar reports across the globe also elucidated high levels of resistance against DEC pathotypes. 
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